Guangmei P. Yan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Anti-CTLA-4 antibody potentiates the antitumor effect of armed oncolytic virus OVM18 via enhancing intratumoral IL-18R1+CD8+ T cells.
Journal: Journal for immunotherapy of cancer
Published: August 24, 2026
Targeting neuronal HK2 alleviates glutamate neurotoxicity and MCAO-induced ischemic brain injury.
Journal: Experimental neurology
Published: January 25, 2026
Investigating oncolytic virus M1-Associated vesicles using 3D electron microscopy.
Journal: Journal of structural biology
Published: November 08, 2025
TAMs-mediated resistance to oncolytic virus M1 in solid tumors.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2025
Retraction Note: DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage.
Journal: Nature communications
Published: October 24, 2025
Identification of YBX1 as an essential host RNA-binding protein governing tumor-selective replication of oncolytic virus M1.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 21, 2025
Oncolytic virus M1 reinvigorates CD8+ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen.
Journal: Cellular & molecular immunology
Published: September 03, 2025
Erratum: IL-6 derived from therapy-induced senescence facilitates the glycolytic phenotype in glioblastoma cells.
Journal: American journal of cancer research
Published: July 30, 2025
IRE1α modulates M1 oncolytic virus sensitivity via ER stress regulation in bladder cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: June 17, 2025
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 10, 2025
Last Updated: 09/26/2026